Daily SPAC Update – April 24, 2024

by | Apr 24, 2024

FNVT Corrects Trust Amount. New Investor Deck for ARYD + Adagio Medical.

Boardroom Alpha SPAC Resources
Full SPAC Listing
SPAC SEC Filings
Boardroom Alpha IPO & SPAC Intelligence Platform (7-Day Trial)

Daily SPAC Update

OTHER SPAC NEWS
ARYD – ARYA SCIENCES ACQUISITION CORP IV * Investor Deck
FNVT – FINNOVATE ACQUISITION CORP * Corrected trust per share in advance of vote * trust $11.32

YESTERDAY’S TOP SPAC GAINERS
19.75% ~ $ 14.37 | PTWO – Pono Capital Two, Inc. (Announced)
4.17% ~ $ 11.98 | FHLT – Future Health ESG Corp. (Pre-Deal)
3.34% ~ $ 13.00 | ALCC – AltC Acquisition Corp. (Announced)
3.33% ~ $ 8.69 | PEGR – Project Energy Reimagined Acquisition Corp. (Announced)
3.11% ~ $ 8.29 | DECA – Denali Capital Acquisition Corp. (Announced)

YESTERDAY’S TOP SPAC LOSERS
-18.71% ~ $ 7.19 | RWOD – Redwoods Acquisition Corp. (Announced)
-3.42% ~ $ 11.59 | HUDA – Hudson Acquisition I Corp. (Pre-Deal)
-1.38% ~ $ 11.45 | BREZ – Breeze Holdings Acquisition Corp (Announced)
-1.02% ~ $ 10.69 | MCAG – Mountain Crest Acquisition Corp. V (Pre-Deal)
-.91% ~ $ 10.87 | VCXB – 10X Capital Venture Acquisition Corp. III (Announced)

Recent Analysis

Daily SPAC Update – May 24, 2024

QRDO To Liquidate at $10.96. ShoulderUp Extends with 1.1M Redemptions. BFAC Extension Vote. Churchill Investor Deck. DIST Merger Agreement.

Daily SPAC Update – May 23, 2024

MAQC + Immersed Inc. Deal Terminated. GPAC Deal Vote Set. IVCB Extends w/ 2.1M Redemptions. CVII Investor Deck. PWUP Redemption Agreement.

Subscribe to Boardroom Alpha Newsletters

Subscribe to Boardroom Alpha's research to receive the latest on governance, SPACs, and people.

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.